Independent register of U.S. FDA drug recalls · updated Oct 11, 2026
RxRecalls Get alerts

Sterility & contamination

A product that must be sterile could not be assured sterile, or was contaminated. A top reason for injectables, eye drops and IV products - loss of sterility assurance can lead to serious infections.

6,317 FDA drug recalls with this cause, newest first.

This is the single biggest cause in the register by a wide margin. It covers products that had to be sterile - injectables, eye drops, certain ointments - but could not be verified sterile, or were found contaminated during testing. Most of these recalls come from compounding pharmacies and outsourcing facilities after an FDA inspection finds gaps in how sterile products were made. Sterility failures are treated seriously because the products involved have the least room for error, going straight into the bloodstream or the eye.

Class II · Moderate risk

Hyaluronidase

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Terminated Sterility / contamination Montana Compounding Pharmacy D-1123-2015
Class II · Moderate risk

Bimix (Phent;pap)

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Terminated Sterility / contamination Montana Compounding Pharmacy D-1120-2015
Class II · Moderate risk

Avastin

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Terminated Sterility / contamination Montana Compounding Pharmacy D-1119-2015
Class II · Moderate risk

Alprostadil

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Terminated Sterility / contamination Montana Compounding Pharmacy D-1118-2015
Class II · Moderate risk

Alprostadil

Lack of Assurance of Sterility; objectionable conditions observed during a FDA inspection

Terminated Sterility / contamination Montana Compounding Pharmacy D-1117-2015
Class II · Moderate risk

5% Dextrose Injection

Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise product sterility.

Terminated Sterility / contamination Baxter Healthcare Corp. NDC 0338-0017-04 D-0426-2015
Class II · Moderate risk

0.9% Sodium Chloride Injection

Lack of Assurance of Sterility. Complaints were receive of missing closures and/or leaks which may compromise product sterility.

Terminated Sterility / contamination Baxter Healthcare Corp. NDC 0338-0049-03 D-0425-2015
Class I · High risk

Lactated Ringer's Irrigation

Non-Sterility: Confirmed customer report of dark, fibrous particulates floating within the solution of the primary container, which were subsequently identified as mold

Terminated Sterility / contamination Hospira Inc. NDC 0409-7828-08 D-1108-2015
Class II · Moderate risk

Fomepizole Injection

Lack of Assurance of Sterility. A recent FDA inspection reported GMP violations potentially impacting product quality and sterility.

Terminated Sterility / contamination Navinta LLC NDC 0781-3182-73 D-0431-2015
Class II · Moderate risk

5% DEXTROSE Injection

Lack of Assurance of Sterility: there is a potential for solution to leak at the administrative port of the primary container.

Terminated Sterility / contamination Hospira Inc. NDC 0409-7100-02 D-0417-2015